Vincerx Pharma, Inc. (VINC)
OTCMKTS · Delayed Price · Currency is USD
0.0314
-0.0059 (-15.82%)
At close: Sep 4, 2025
Vincerx Pharma Market Cap
Vincerx Pharma has a market cap or net worth of $195.24 thousand as of September 4, 2025. Its market cap has decreased by -98.94% in one year.
Market Cap
195.24K
Enterprise Value
-4.24M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since May 27, 2020, Vincerx Pharma's market cap has decreased from 22.32M to 195.24K, a decrease of -99.13%. That is a compound annual growth rate of -59.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 195.24K | -97.79% |
| Dec 31, 2024 | 8.84M | -64.95% |
| Dec 29, 2023 | 25.23M | 16.73% |
| Dec 30, 2022 | 21.61M | -89.91% |
| Dec 31, 2021 | 214.20M | -26.75% |
| Dec 31, 2020 | 292.41M | 1,210.19% |
| May 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 891.61M |
| Elite Pharmaceuticals | 751.15M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 631.79M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 394.86M |
| American Oncology Network | 353.52M |